Matches in SemOpenAlex for { <https://semopenalex.org/work/W2070473681> ?p ?o ?g. }
- W2070473681 endingPage "1554" @default.
- W2070473681 startingPage "1543" @default.
- W2070473681 abstract "Success of hematopoietic cell transplantation (HCT) can vary by race, but the impact of socioeconomic status (SES) is not known. To evaluate the role of race and SES, we studied 6207 unrelated-donor myeloablative (MA) HCT recipients transplanted between 1995 and 2004 for acute or chronic leukemia or myelodysplastic syndrome (MDS). Patients were reported by transplant center to be White (n = 5253), African American (n = 368), Asian/Pacific-Islander (n = 141), or Hispanic (n = 445). Patient income was estimated from residential zip code at time of HCT. Cox regression analysis adjusting for other significant factors showed that African American (but not Asian or Hispanic) recipients had worse overall survival (OS) (relative-risk [RR] 1.47; 95% confidence interval [CI] 1.29-1.68, P < .001) compared to Whites. Treatment-related mortality (TRM) was higher in African Americans (RR 1.56; 95% CI 1.34-1.83, P < .001) and in Hispanics (RR 1.30; 95% CI 1.11-1.51, P = .001). Across all racial groups, patients with median incomes in the lowest quartile (<$34,700) had worse OS (RR 1.15; 95% CI 1.04-1.26, P = .005) and higher risks of TRM (RR 1.21; 1.07-1.36, P = .002). Inferior outcomes among African Americans are not fully explained by transplant-related factors or SES. Potential other mechanisms such as genetic polymorphisms that have an impact on drug metabolism or unmeasured comorbidities, socioeconomic factors, and health behaviors may be important. Low SES, regardless of race, has a negative impact on unrelated donor HCT outcomes. Success of hematopoietic cell transplantation (HCT) can vary by race, but the impact of socioeconomic status (SES) is not known. To evaluate the role of race and SES, we studied 6207 unrelated-donor myeloablative (MA) HCT recipients transplanted between 1995 and 2004 for acute or chronic leukemia or myelodysplastic syndrome (MDS). Patients were reported by transplant center to be White (n = 5253), African American (n = 368), Asian/Pacific-Islander (n = 141), or Hispanic (n = 445). Patient income was estimated from residential zip code at time of HCT. Cox regression analysis adjusting for other significant factors showed that African American (but not Asian or Hispanic) recipients had worse overall survival (OS) (relative-risk [RR] 1.47; 95% confidence interval [CI] 1.29-1.68, P < .001) compared to Whites. Treatment-related mortality (TRM) was higher in African Americans (RR 1.56; 95% CI 1.34-1.83, P < .001) and in Hispanics (RR 1.30; 95% CI 1.11-1.51, P = .001). Across all racial groups, patients with median incomes in the lowest quartile (<$34,700) had worse OS (RR 1.15; 95% CI 1.04-1.26, P = .005) and higher risks of TRM (RR 1.21; 1.07-1.36, P = .002). Inferior outcomes among African Americans are not fully explained by transplant-related factors or SES. Potential other mechanisms such as genetic polymorphisms that have an impact on drug metabolism or unmeasured comorbidities, socioeconomic factors, and health behaviors may be important. Low SES, regardless of race, has a negative impact on unrelated donor HCT outcomes." @default.
- W2070473681 created "2016-06-24" @default.
- W2070473681 creator A5000120418 @default.
- W2070473681 creator A5003621767 @default.
- W2070473681 creator A5008575399 @default.
- W2070473681 creator A5019494133 @default.
- W2070473681 creator A5021313031 @default.
- W2070473681 creator A5021909393 @default.
- W2070473681 creator A5024612727 @default.
- W2070473681 creator A5028145044 @default.
- W2070473681 creator A5028679464 @default.
- W2070473681 creator A5029125087 @default.
- W2070473681 creator A5031293676 @default.
- W2070473681 creator A5031390636 @default.
- W2070473681 creator A5042915360 @default.
- W2070473681 creator A5042962214 @default.
- W2070473681 creator A5045171992 @default.
- W2070473681 creator A5045583767 @default.
- W2070473681 creator A5063351800 @default.
- W2070473681 creator A5064818358 @default.
- W2070473681 creator A5072480385 @default.
- W2070473681 creator A5077395403 @default.
- W2070473681 creator A5077928113 @default.
- W2070473681 creator A5078452182 @default.
- W2070473681 creator A5081868521 @default.
- W2070473681 creator A5082092102 @default.
- W2070473681 creator A5082589346 @default.
- W2070473681 creator A5087810873 @default.
- W2070473681 date "2009-12-01" @default.
- W2070473681 modified "2023-10-16" @default.
- W2070473681 title "Race and Socioeconomic Status Influence Outcomes of Unrelated Donor Hematopoietic Cell Transplantation" @default.
- W2070473681 cites W1506967847 @default.
- W2070473681 cites W1936274243 @default.
- W2070473681 cites W1951884638 @default.
- W2070473681 cites W1963608427 @default.
- W2070473681 cites W1973248441 @default.
- W2070473681 cites W1973822496 @default.
- W2070473681 cites W1977284131 @default.
- W2070473681 cites W1977415173 @default.
- W2070473681 cites W1982378111 @default.
- W2070473681 cites W1995990939 @default.
- W2070473681 cites W1999720425 @default.
- W2070473681 cites W2001036195 @default.
- W2070473681 cites W2003832151 @default.
- W2070473681 cites W2005499564 @default.
- W2070473681 cites W2009532963 @default.
- W2070473681 cites W2021026872 @default.
- W2070473681 cites W2039105238 @default.
- W2070473681 cites W2040886821 @default.
- W2070473681 cites W2044302296 @default.
- W2070473681 cites W2044382965 @default.
- W2070473681 cites W2046684509 @default.
- W2070473681 cites W2057454861 @default.
- W2070473681 cites W2061206411 @default.
- W2070473681 cites W2069326820 @default.
- W2070473681 cites W2069410101 @default.
- W2070473681 cites W2079241332 @default.
- W2070473681 cites W2079685822 @default.
- W2070473681 cites W2088004131 @default.
- W2070473681 cites W2089398850 @default.
- W2070473681 cites W2089998734 @default.
- W2070473681 cites W2093746406 @default.
- W2070473681 cites W2104152182 @default.
- W2070473681 cites W2118033225 @default.
- W2070473681 cites W2126695445 @default.
- W2070473681 cites W2132208474 @default.
- W2070473681 cites W2147015593 @default.
- W2070473681 cites W2150355770 @default.
- W2070473681 cites W2156925439 @default.
- W2070473681 cites W2157329913 @default.
- W2070473681 cites W2159035726 @default.
- W2070473681 cites W2163370023 @default.
- W2070473681 cites W2164479582 @default.
- W2070473681 cites W4232993147 @default.
- W2070473681 cites W4299962466 @default.
- W2070473681 cites W4376595310 @default.
- W2070473681 doi "https://doi.org/10.1016/j.bbmt.2009.07.023" @default.
- W2070473681 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2775819" @default.
- W2070473681 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19896078" @default.
- W2070473681 hasPublicationYear "2009" @default.
- W2070473681 type Work @default.
- W2070473681 sameAs 2070473681 @default.
- W2070473681 citedByCount "122" @default.
- W2070473681 countsByYear W20704736812012 @default.
- W2070473681 countsByYear W20704736812013 @default.
- W2070473681 countsByYear W20704736812014 @default.
- W2070473681 countsByYear W20704736812015 @default.
- W2070473681 countsByYear W20704736812016 @default.
- W2070473681 countsByYear W20704736812017 @default.
- W2070473681 countsByYear W20704736812018 @default.
- W2070473681 countsByYear W20704736812019 @default.
- W2070473681 countsByYear W20704736812020 @default.
- W2070473681 countsByYear W20704736812021 @default.
- W2070473681 countsByYear W20704736812022 @default.
- W2070473681 countsByYear W20704736812023 @default.
- W2070473681 crossrefType "journal-article" @default.
- W2070473681 hasAuthorship W2070473681A5000120418 @default.
- W2070473681 hasAuthorship W2070473681A5003621767 @default.